FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq:GILD) provided an update today on the development of the fixed-dose combination of Truvada ® (emtricitabine and tenofovir ...

A clinical trial showed that fewer participants contracted HIV after being injected with the drug cabotegravir than those who took a daily dose of Truvada A new study may alter the course of HIV ...

These generic treatments have similar safety profiles to their reference products. The first generic versions of Truvada (emtricitabine, tenofovir disoproxil fumarate) and Atripla (efavirenz, ...

Women need daily doses of the antiviral medication Truvada to prevent HIV infection while men only need two doses per week due to the way the drug accumulates in different body tissues, according to a ...

(RTTNews) - Gilead Sciences, Inc. (GILD) said Tuesday that the China National Medical Products Administration or NMPA has approved a pre-exposure prophylaxis indication for its blockbuster HIV drug ...

GlaxoSmithKline said an injection every other month of its cabotegravir drug was shown to avert an HIV infection more effectively than Gilead's daily Truvada pill, potentially giving its ViiV unit a ...

The pre-exposure prophylaxis treatment Truvada has not been as effective in the prevention of HIV in women as it has in men. A recent study published in The Journal of Infectious Diseases examines the ...

Gilead Sciences, makers of HIV prevention drug Truvada, have announced that a generic version will be available as early as September 2020. Truvada, also called PrEP, is a daily pill that prevents ...

A Food and Drug Administration (FDA) panel is debating whether to make history by recommending approval of the first drug to prevent HIV infection. The advisory committee is expected to vote on ...

Gilead Sciences announced Wednesday that a generic version of Truvada will be available in September 2020, one year earlier than expected. Subscribe to read this story ad-free Get unlimited access to ...